Fractyl Health (GUTS) Non-Current Assets (2023 - 2026)
Fractyl Health (GUTS) reported Non-Current Assets of $33.5 million for Q1 2026, down 7.03% year-on-year from $36.0 million in Q1 2025, and down 1.07% quarter-over-quarter from $33.8 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Non-Current Assets data on file, last reported at $33.5 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 7.03% year-over-year to $33.5 million; the trailing twelve-month figure through Mar 2026 stood at $137.2 million (down 9.43% YoY), and the FY2025 full-year result was $33.8 million, down 6.85% from the prior year.
- Non-Current Assets for Q1 2026 stood at $33.5 million, down from $33.8 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $40.6 million in Q4 2023 and bottomed at $33.5 million in Q1 2026.
- A 4-year average of $36.8 million and a median of $36.2 million in 2024 frame the typical range for Non-Current Assets.
- Peak annual rise in Non-Current Assets reached 6.85% in 2025, while the deepest fall reached 11.98% in 2025.
- Tracing GUTS's Non-Current Assets over 4 years: stood at $40.6 million in 2023, then slipped by 10.48% to $36.3 million in 2024, then fell by 6.85% to $33.8 million in 2025, then fell by 1.07% to $33.5 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $33.5 million, $33.8 million, and $34.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 22.66 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 33.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.47 Mn |
| Dec 31, 2025 | 33.83 Mn |
| Sep 30, 2025 | 34.57 Mn |
| Jun 30, 2025 | 35.32 Mn |
| Mar 31, 2025 | 36.00 Mn |
| Dec 31, 2024 | 36.31 Mn |
| Sep 30, 2024 | 39.27 Mn |
| Jun 30, 2024 | 39.88 Mn |
| Mar 31, 2024 | 39.05 Mn |
| Dec 31, 2023 | 40.56 Mn |